A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase
Tourtellotte, W.W.; Syndulko, K.; Baumhefner, R.W.; Shapshak, P.; Osborne, M.
Neurology 38(7 Suppl 2: 83-86
1988
ISSN/ISBN: 0028-3878 PMID: 3386848 Document Number: 316601
Document emailed within 1 workday
Related Documents
Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541
Castro, H.J.; Mendez-Lnocencio, J.I.; Omidvar, B.; Omidvar, J.; Santilli, J.; Nielsen, H.S.; Pavot, A.P.; Richert, J.R.; Bellanti, J.A. 2005: A phase i study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis Allergy and Asthma Proceedings 26(6): 470-476
Hauser, S.L.; Fosburg, M.; Kevy, S.V.; Weiner, H.L. 1984: Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects Neurology 34(7): 922-926
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1989: Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression Neurologia i Neurochirurgia Polska 23(3): 188-192
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1988: Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 22(5): 399-403
Frick, E.; Angstwurm, H.; Strauss, G. 1974: Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin Münchener Medizinische Wochenschrift 116(48): 2105-2112
Feys, P.; Bibby, B.M.; Baert, I.; Dalgas, U. 2015: Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis European Journal of Physical and Rehabilitation Medicine 51(2): 207-210
Watanabe, T.; Yamamoto, T.; Saito, T.; Sugano, M.; Tsukamoto, T. 1993: Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis Rinsho Shinkeigaku 33(1): 15-20
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Kastrukoff, L.F.; Oger, J.J.; Tourtellotte, W.W.; Sacks, S.L.; Berkowitz, J.; Paty, D.W. 1991: Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation Neurology 41(12): 1936-1941
Zephir, H.; De-Seze, J.; Senechal, O.; Stojkovic, T.; Ferriby, D.; Delisse, B.; Dubus, B.; Verier, A.; Hautecoeur, P.; Vermersch, P. 2002: Treatment of progressive multiple sclerosis with cyclophosphamide Revue Neurologique (Paris) 158(1): 65-69
Edan, G. 2001: Treatment of progressive forms of multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 2): 1008-1013
Lebrun, C. 2001: Beta-interferon clinical trials using MRI in patients with multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 761-767
Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up Acta Neurologica 15(1): 33-43
Nomura, M.; Suzumura, A.; Anno, H.; Miyata, E.; Koga, S.; Yamamoto, H. 1995: Clinical usefulness of MRi in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase Rinsho Shinkeigaku 35(3): 225-230
Bergamaschi, R.; Citterio, A.; Filippini, G.; Cosi, V. 1993: Clinical trials in multiple sclerosis: a critical review (1970-1990) Acta Neurologica 15(6): 462-474
Henneberg, A.; Mayle, D.M.; Pfau, J.U.; Hartmann, P.; Elsner, U.; Kornhuber, H.H. 1994: Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course Zeitschrift für Arztliche Fortbildung 88(7-8): 593-596
Evtushenko, S.K.; Kharaberiush, V.A.; Kvasha, V.I.; Kopyl, G.M.; Dvukhovnaia, M.A. 1983: Drainage of the thoracic duct in the complex treatment of progressive forms of multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(6): 890-897
Ouyang, J.; Ni, X.; Chen, B. 2001: A preliminary result of treatment of progressive multiple sclerosis with autologous peripheral blood stem cell transplantation in China Zhonghua Nei Ke Za Zhi 40(8): 550-552